Medical management of severe, ulcerative colitis

被引:20
作者
Chang, JC [1 ]
Cohen, RD [1 ]
机构
[1] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.gtc.2004.02.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The medical management of patients with severe ulcerative colitis requires initial stabilization, careful and repeated evaluations to exclude confounding or coexisting diagnoses, and timely delivery of appropriate medications. Medical therapies for these patients are potent but may be toxic, and administration must be done by experienced medical professionals, with adequate access to appropriate laboratory radiographic, endoscopic, and surgical facilities. Patients who fail to respond to high-dose intravenous corticosteroids in a timely basis should be evaluated for cyclosporin therapy, or proceed to surgery. The promise of newer, investigational therapies to induce and maintain remission must be borne out by large controlled trials.
引用
收藏
页码:235 / +
页数:17
相关论文
共 91 条
[1]   CONTINUOUSLY INFUSED CYCLOSPORINE AT LOW-DOSE IS SUFFICIENT TO AVOID EMERGENCY COLECTOMY IN ACUTE ATTACKS OF ULCERATIVE-COLITIS WITHOUT THE NEED FOR HIGH-DOSE STEROIDS [J].
ACTIS, GC ;
OTTOBRELLI, A ;
PERA, A ;
BARLETTI, C ;
PONTI, V ;
PINNAPINTOR, M ;
VERME, G .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 17 (01) :10-13
[2]   Infliximab for treatment of steroid-refractory ulcerative colitis [J].
Actis, GC ;
Bruno, M ;
Pinna-Pintor, M ;
Rossini, FP ;
Rizzetto, M .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (09) :631-634
[3]   Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial [J].
Actis, GC ;
Aimo, G ;
Priolo, G ;
Moscato, D ;
Rizzetto, M ;
Pagni, R .
INFLAMMATORY BOWEL DISEASES, 1998, 4 (04) :276-279
[4]   Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease [J].
Ang, YS ;
Mahmud, N ;
White, B ;
Byrne, M ;
Kelly, A ;
Lawler, M ;
McDonald, GSA ;
Smith, OP ;
Keeling, PWN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1015-1022
[5]   Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis [J].
Ardizzone, S ;
Molteni, F ;
Imbesi, V ;
Bollani, S ;
Porro, GB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1997, 25 (01) :330-333
[6]   A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis [J].
Ayabe, T ;
Ashida, T ;
Taniguchi, M ;
Nomura, M ;
Einami, K ;
Taruishi, M ;
Saitoh, Y ;
Santos, SB ;
Ono, M ;
Shibata, Y ;
Kohgo, Y .
INTERNAL MEDICINE, 1997, 36 (05) :322-326
[7]  
BANKS BM, 1957, GASTROENTEROLOGY, V32, P983
[8]  
BIERER BE, 1995, P ASSOC AM PHYSICIAN, V107, P28
[9]   Oral tacrolimus treatment of severe colitis in children [J].
Bousvaros, A ;
Kirschner, BS ;
Werlin, SL ;
Parker-Hartigan, L ;
Daum, F ;
Freeman, KB ;
Balint, JP ;
Day, AS ;
Griffiths, AM ;
Zurakowski, D ;
Ferry, GD ;
Leichtner, AM .
JOURNAL OF PEDIATRICS, 2000, 137 (06) :794-799
[10]   Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis [J].
Brigidi, P ;
Swennen, E ;
Rizzello, F ;
Bozzolasco, M ;
Matteuzzi, D .
JOURNAL OF CHEMOTHERAPY, 2002, 14 (03) :290-295